FDA-Drug2026-01-14Class IIPACKAGING DEFECT
Imprimis Dexamethasone Moxifloxacin eye injection recalled for glass-like particles
What this means
Imprimis NJOF, LLC is recalling specific lots of Dexamethasone Moxifloxacin intraocular injection due to the presence of glass-like particles in the medication. This injection is used during eye surgery. Two affected lots have been identified and distributed nationwide.
- If you have received this injection or your eye surgery is scheduled, contact your ophthalmologist or surgical facility immediately
- Do not use affected lots 25MAY051 or 25AUG003
- Ask your healthcare provider whether your procedure used medication from these lots
The agency's original wording
Hazard
Presence of particulate matter - Glass like particles.
Intended for
Adults
Illnesses reported
None reported
Sold states
U.S Nationwide
Affected count
778 boxes of 15,540 pre-filled syringes
Manufactured in
1705 Route 46 Ste 6B, Ledgewood, NJ, United States
Products
Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0249-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.